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A Look at Tuberculosis and Its Relationship to
HIV/AIDS
Kenneth D. Phillips, PhD, RN
As nursing students in the 1970s, my classmates
and I were told that tuberculosis (TB) was on the
verge of being eradicated globally. At that time, TB
could have been definitively diagnosed and afford-
ably treated with standard, affordable, first-line
drugs. Unfortunately, that possibility was never real-
ized. The growing TB epidemic was a pervasive
theme at The XVI International AIDS Conference.
At the conference it was reported that two billion
people, one third of the world’s population, are be-
lieved to be infected with TB. Each year, 8 million
people develop active TB, and nearly 2 million peo-
ple with active TB die. In 2005, 14,093 cases of
active TB were diagnosed in the United States, and it
is believed that as many as 15 million U.S. residents
are latently infected with TB (Avert, 2006; National
Institute of Allergy and Infectious Diseases, 2006).
TB and HIV/AIDS are inseparably linked, and
these infections occur most frequently in economi-
cally deprived regions of the developing world. The
immunodeficiency caused by HIV infection reacti-
vates latent TB infection and accelerates the progres-
sion of newly acquired TB (Hausler et al., 2006). TB
is one of the defining illnesses that marks the pro-
gression of HIV infection to AIDS (Avert, 2006), and
it is responsible for one third of all HIV-related
deaths (Avert, 2006; Raviglione et al., 1997), making
it the leading cause of death for persons living with
AIDS (Centers for Disease Control and Prevention,
2005; Harries, 2000; Raviglione, Harries, Msiska,
Wilkinson, & Nunn, 1997).
TB infection can be latent or active. In the latent
form it is held at bay by the immune system, does not
cause illness, and cannot be spread from one person
to another. In the active state it can be transmitted to
others, and severe illness and death can result if it is
not diagnosed and effectively treated. Anyone who is
latently infected is at risk of developing active TB
later in life if his or her immune system fails.
Unlike HIV infection, which is not spread by
casual contact, TB infection can be acquired by
healthy individuals who inhale Mycobacterium tu-
berculosis. TB is more likely to be spread in crowded
living conditions (such as homeless shelters, prisons,
or crowded homes) and areas of high prevalence in
which uninfected individuals are in close proximity
with persons with active TB.
The first call for the elimination of TB in the
United States was issued in the 1930s, and that call
has been reissued in each successive decade. In an
editorial published in the American Journal of Public
Health in February 1972, Kimmey asked, “What
needs to be done to eradicate tuberculosis?” In July
of that same year, Rosenblatt, the state TB control
officer of New Mexico, responded with these words:
To me, the most important question in this context
appears to be this: Is eradication of tuberculosis
needed? Without doubt, it would be desirable. But
how much would we accomplish, following the
author’s plan, as compared with the Herculean
effort necessary to carry out such a plan? If ev-
erything were feasible and worked out properly,
we or our successors would, let us say within the
next thirty years, have buried the bulk of presently
known infected (without preceding slaughter, of
course) and, within seventy years, almost all of
them. All along however, we would have a con-
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tinued influx of infected persons from other coun-
tries, already a considerable source of new cases
for certain states. Unless we extended our efforts
all over the world, this would perpetuate our task.
This then would be a rather modest result, con-
sidering the fantastic cost involved in carrying out
all the testing (Rosenblatt, 1972, p. 905).
In the 1980s after a resurgence of TB in the United
States, once again scientists recognized the great need
for its elimination. Unfortunately, it was not TB that
was eliminated; the funds specifically targeted at TB
have been reduced if not eliminated at all levels of
government (Institute of Medicine [IOM], 2000). The
United States has been neglectful of TB within its own
borders and virtually absent in the TB pandemic in the
rest of the world. That neglect has led to a resurgence of
TB and to the appearance of multiple drug resistant
tuberculosis (MDRTB).
Three decades later, I would like to respond to the
views presented by Rosenblatt. Of course Rosenblatt
could not have predicted the appearance of HIV/
AIDS at the beginning of the 1980s—no one could
have—but yes, even in the absence of HIV/AIDS,
eradication of TB was needed. The shortsightedness
and the isolationist policies of political leaders
around the world have allowed MDRTB to spread at
alarming rates.
Yes, the influx of persons from other countries
who are infected with TB has continued and will
continue. More than half of the cases of TB in the
United States occur in persons born outside of the
United States. Today, our borders are open, and
immigration to the United States, for the most part, is
uncontrolled. Elimination of TB in the United States
will not occur without global attention to this epi-
demic, universal testing of immigrants to the United
States, and effective treatment for persons with latent
or active TB.
Yes, we should have extended our efforts all over
the world. In the 1970s, U.S. citizens traveled outside
the country less frequently. Now, international travel
to and from areas where TB is endemic is common-
place. It would be of great benefit to us to help in
prevention and treatment efforts around the globe.
Yes, identifying and treating cases of TB in the
1970s would have come at enormous cost. However,
the direct costs of treating nonresistant TB at that
time would have been far less than treating MDRTB,
which has spread exponentially in the 21st century.
Effective treatment for TB in impoverished areas of
the world will help persons with TB live longer and
better quality lives and will limit the spread of
MDRTB to residents of the industrialized world.
Not all of the costs of TB can be measured in
dollars. Globally, TB affects persons in the most
productive years of their lives. Eighty percent of all
persons with TB are between the ages of 15 and 49.
The costs are the loss of productivity as a result of the
illness, loss of life, and loss of financial support for
the family of the person with TB. Death of parents in
this age group as a result of TB and HIV infection is
leading to an unprecedented number of orphaned
children who are left with aged grandparents, in
orphanages, or to their own devices. Yes, there could
have been enormous savings accounted for by erad-
icating TB.
The World Health Organization has estimated that
one third of the world’s population has been infected
with Mycobacterium tuberculosis. In the next de-
cade, it is estimated that more than 20 million people
worldwide will die as a result of TB. A combination
of five drugs given over 6 to 9 months effectively
treats tubercular disease. These drugs are isoniazid,
rifampin, pyrazinamide, and ethambutol or strepto-
mycin. Streptomycin, the first effective antitubercu-
lar drug, was discovered in 1944. It is unbelievable
that no new antitubercular drugs have been devel-
oped since ethambutol was discovered in 1967. The
failure of pharmaceutical companies to develop other
chemotherapeutic agents because there is not a profit
motive is disgraceful. Twenty efficacious antiretro-
viral drugs have been discovered since the recogni-
tion of HIV infection in 1981. There have been
strong advocates for persons with HIV/AIDS. Where
are advocates for poor people around the world at
risk for death from TB? For that matter, where are the
activists for HIV/AIDS today?
Mycobacterium tuberculosis is classified as mul-
tiple drug resistant when it is at least resistant to
isoniazid and rifampicin. Now there are strains of
Mycobacterium tuberculosis that are resistant to all
antitubercular drugs. Even though MDRTB can be
effectively treated, the course of treatment may be
twice as long and cost as much as 100 times more
than treating TB that is not multidrug resistant.
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A human vaccine made from attenuated bovine
TB, called bacille Calmette-Guerin (BCG), was dis-
covered by two French scientists and made available
in the 1920s. BCG provides immunity for 30% to
80% of those who are vaccinated. This vaccine is not
used widely in the United States or other countries in
which the incidence of TB is lower, but BCG vacci-
nation is considered a priority in countries in which
the incidence of TB is rapidly increasing. Reports of
the safety and efficacy of BCG have varied, and
vaccination with BCG makes interpretation of the TB
skin test more difficult. In countries in which the
vaccine has been administered, the mortality rate has
declined strikingly. Why has there not been a safer
and more efficacious vaccine developed since the
1920s? Once again, the profit motive is absent.
In this decade, there is yet another call for eradi-
cation of TB in the United States. The prevalence of
TB is at a record low in this country, and this is
within the realm of possibility. The IOM has pub-
lished a detailed plan for eliminating TB in the
United States (IOM, 2000). The American Thoracic
Society, the Infectious Diseases Society of America,
and the Centers for Disease Control and Prevention
(Taylor, Nolan, & Blumberg, 2005) have published
joint recommendations aimed at ending TB in the
United States. These guidelines provide valuable di-
rection for this country. What is needed is a best-
evidence guideline for ending global TB.
Implications for Nurses in AIDS Care
Many people, healthcare workers and lay persons
alike, have overcome their ignorance and fear about
the modes of transmission of HIV infection and have
joined the ranks to care for persons living with HIV/
AIDS. Even health care workers, who are comfort-
able with providing care for persons with HIV/AIDS,
which is not spread by casual contact, are concerned
about the risk of acquiring TB, which is spread from
the respiratory system of one person to the respira-
tory system of another person. To become infected
with TB, a person must inhale only a small number
of the bacilli. With proper equipment and precau-
tions, the risk of infection is minimized. In impov-
erished nations where the infection rate is high and
sanitation measures, antitubercular drugs, and isola-
tion equipment are very limited, the fear of TB may
deter some persons from providing care to HIV-
infected individuals. As was pointed out in this
year’s conference, Kenyan hospital workers are at
increased risk for occupationally acquired TB. In a
case-control study presented at the conference by
Dalai et al. (2006), factors that were independently
associated with TB infection among the hospital
workers were being HIV-infected themselves (odd
ratio [OR] 33, 95%; confidence interval [CI] 5.7-
192), having greater than 5 hours of patient contact
per day (OR 6.5, 95%; CI 2.3-18.4), and working in
areas where TB patients receive care (OR 2.2, 95%;
CI 1.1-4.4).
Another key consideration for nurses in AIDS care
is that activation of the immune system by TB ac-
celerates the progression of HIV/AIDS, and many
HIV-related deaths can be attributed to TB. Sixty
percent of HIV-infected persons in Africa will die as
a result of TB.
Several studies at this year’s conference showed
that HIV/AIDS and tuberculosis are strongly associ-
ated with poverty (Bachmann & Booysen, 2006;
Langlo, Pierotti, Atim, Ojom, & Cioantia, 2006; Up-
ham & Kaitiritimba, 2006), and one presentation
linked the spread of HIV/AIDS and tuberculosis with
global capitalization (Newman, 2006). The poor
must have advocates to speak for them, and nurses in
TB and AIDS care must become advocates of the
poor. TB and HIV infection occur more frequently
and are the most common causes of death in poverty-
stricken areas of the world (Mhalu, 2005). In almost
all situations, TB and HIV diminish a family’s in-
come level and standard of living, and separately and
together, TB and HIV infection force approximately
30% of families below the poverty level (Wiker,
Mustafa, Malen, & Riise, 2006). As Benatar (1995)
points out, “Failure to appreciate that the emergence
and spread of infectious diseases (afflicting predom-
inately the poor) are attributable to the ideology and
economic forces that perpetuate poverty, will dimin-
ish our ability to control HIV/AIDS and tuberculosis
and probably favour the emergence of more new
infections” (Benatar, 1995, p. 235). We must hold the
political leaders of all nations accountable for the use
of resources in ways that will benefit the health of
humankind. Industrialized (wealthy) nations have a
responsibility to the developing (impoverished) na-
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tions of the world, but we are reminded by Benatar
(1995) that development aid is often a smokescreen
for robbing them of their resources.
As nurses in AIDS care, we must continue our
advocacy and care for persons living with HIV/
AIDS, but we must also join the fight against TB and
other infectious diseases. It is impossible to effec-
tively care for persons with HIV/AIDS without pro-
viding care for other infectious diseases. The IOM
has pointed out that there is a decline in the number
of health care professionals who are experts in the
prevention, diagnosis, and treatment of TB (IOM,
2000). The Association of Nurses in AIDS Care should
consider broadening its sphere of concern to other life-
threatening infections, and nurses in AIDS care must
develop expertise in the prevention, treatment, and
eradication of other infectious diseases. A task force to
develop recommendations for nursing’s response to TB
and HIV coinfection is recommended.
During the decade of compassionate conservatism,
there has been much talk about morality. For the
most part that talk has centered on sexual and repro-
ductive matters, and very little concern has been
expressed and far less action has been taken regard-
ing the enormous moral imperatives of caring for
others, treating others with respect, feeding the hun-
gry, providing clothing for those in need, offering
shelter for the homeless, and providing comfort and
treatment for those who are ill. How moral is this?
(Kimmey, 1972).
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